Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

Fig. 1

Disposition of the study patients. Of the 157 patients we recruited at a total of 14 centers, 147 met inclusion/exclusion criteria and then randomized to either the BP arm (n = 71) or the EP arm (n = 76). In the BP arm, the number of the patients of the mITT set, the PP set and the safety set were 71, 57 and 70, respectively. In the EP arm, these values were 76, 63 and 77 in the corresponding order

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us